Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine

Apr 26, 2021 7:00am EDT

Baudax Bio Announces Partial Adjournment of Annual Meeting of Shareholders

Apr 08, 2021 4:05pm EDT

Baudax Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 01, 2021 7:00am EDT

Baudax Bio to Participate at the Oppenheimer 31st Annual Healthcare Conference

Mar 10, 2021 7:00am EST

Baudax Bio Strengthens Management Team with Appointment of Richard S. Casten as Chief Financial Officer

Mar 08, 2021 7:00am EST

Baudax Bio to Present at the H.C. Wainwright Global Life Sciences Conference

Mar 02, 2021 7:00am EST

Baudax Bio Reports 2020 Annual Financial Results

Feb 16, 2021 7:00am EST

Baudax Bio to Report 2020 Annual Financial Results and Host Conference Call and Webcast on February 16, 2021

Feb 10, 2021 8:04am EST

Baudax Bio Announces $17.6 Million Offering Priced At-the-Market under Nasdaq Rules

Feb 08, 2021 3:24pm EST

Baudax Bio Announces Exercise of Warrants for Gross Proceeds of $13.4 Million

Jan 21, 2021 9:28am EST